Thursday, July 06, 2023 9:36:06 AM
https://www.accesswire.com/765775/RMEDs-LockeT-Device-Utilized-in-Structural-Heart-Procedures
Provides Evidence of Efficacy in Large Diameter Sheath Procedures, Expanding Use Beyond Electrophysiology Market
FORT MILL, SC / ACCESSWIRE / July 6, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) today announced that its new LockeT device, used as a suture retention device for percutaneous closures, has now been utilized in structural heart procedures. The latest use was in six patients undergoing Watchman & Amulet procedures, where the left atrial appendage is closed off in patients with atrial fibrillation, and two patients receiving the AVEIR Leadless Pacemaker at HCA Trident Medical Center in North Charleston, South Carolina.
HCA Trident Medical Center's Dr. Frank Cuoco, commented, "The LockeT device is another tool in our arsenal that provides ease of use and greatly assists in the femoral closure of the openings from large diameter sheaths. The LockeT allows for greater patient comfort, and hemostasis is achieved in a matter of minutes."
David Jenkins, interim CEO of Ra Medical stated, "Although the electrophysiology market is quite large, we are pleased that the additional evidence of the LockeT use within the structural heart market takes us beyond electrophysiology procedures, and includes not only the LAA device implants, but also the TAVR devices, and certain pacemaker devices such as the AVEIR leadless pacemaker.
Watchman is a product and trademark of Boston Scientific (BSX). AMULET and AVEIR are products and trademark of Abbott (ABT).
Recent RMED News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/03/2024 09:02:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/03/2024 09:01:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:20:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:16:48 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:19:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 08:16:05 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/20/2023 08:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:15:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM